The Transcription Therapy Symposium will feature thought leaders at the interface of chemical and biomedical sciences, offering participants the opportunity to learn and explore scientific advances in chromatin and gene regulation, transcription-targeted therapeutics and more. Hosted by the St. Jude Department of Chemical Biology and Therapeutics and the St. Jude Comprehensive Cancer Center, this virtual event will be held on September 24, 2020.

Disruption of chromatin, epigenetic states and transcriptional regulation can lead to disease, including pediatric cancers. As our understanding of mechanisms of transcriptional regulation increases, so does our ability to rationally design molecules with therapeutic potential that target these processes. This symposium will explore chemical approaches to elucidating and regulating chromatin and epigenetic landscapes, and mechanistically guided approaches to remedying dysfunctional gene regulation in human disease.

Learn about transcription therapy at St. Jude

Speakers
Aseem Ansari
St. Jude Children’s Research Hospital

Paramjit (Bobby) Arora, PhD
New York University

Stephen Frye, PhD
University of North Carolina, Chapel Hill

​Nathanael S. Gray, PhD
Stanford University

Anna Mapp, PhD
University of Michigan

Tom Muir, PhD
Princeton University

Charles W.M. Roberts, MD, PhD
St. Jude Children’s Research Hospital

Joanna Wysocka, PhD
Stanford University

Richard A. Young, PhD
Whitehead Institute
Massachusetts Institute of Technology